Literature DB >> 24240640

Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formation.

Igor F Tsigelny1, Yuriy Sharikov2, Valentina L Kouznetsova3, Jerry P Greenberg4, Wolfgang Wrasidlo5, Tania Gonzalez6, Paula Desplats6, Sarah E Michael6, Margarita Trejo-Morales6, Cassia R Overk6, Eliezer Masliah7.   

Abstract

Alzheimer's disease (AD) is associated with the formation of toxic amyloid-β (Aβ)42 oligomers, and recent evidence supports a role for Aβ dimers as building blocks for oligomers. Molecular dynamics simulation studies have identified clans for the dominant conformations of Aβ42 forming dimers; however, it is unclear if a larger spectrum of dimers is involved and which set(s) of dimers might evolve to oligomers verse fibrils. Therefore, for this study we generated multiple structural conformations of Aβ42, using explicit all-atom molecular dynamics, and then clustering the different structures based on key conformational similarities. Those matching a selection threshold were then used to model a process of oligomerization. Remarkably, we showed a greater diversity in Aβ dimers than previously described. Depending on the clan family, different types of Aβ dimers were obtained. While some had the tendency to evolve into oligomeric rings, others formed fibrils of diverse characteristics. Then we selected the dimers that would evolve to membranephilic annular oligomers. Nearly one third of the 28 evaluated annular oligomers had the dimer interfaces between the neighboring Aβ42 monomers with possible salt bridges between the residue K28 from one side and either residue E22 or D23 on the other. Based on these results, key amino acids were identified for point mutations that either enhanced or suppressed the formation and toxicity of oligomer rings. Our studies suggest a greater diversity of Aβ dimers. Understanding the structure of Aβ dimers might be important for the rationale design of small molecules that block formation of toxic oligomers.

Entities:  

Keywords:  Dimers; molecular dynamics; neurodegeneration; oligomers; synaptoxicity

Mesh:

Substances:

Year:  2014        PMID: 24240640      PMCID: PMC4449729          DOI: 10.3233/JAD-131589

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  76 in total

1.  Assembly and kinetic folding pathways of a tetrameric beta-sheet complex: molecular dynamics simulations on simplified off-lattice protein models.

Authors:  Hyunbum Jang; Carol K Hall; Yaoqi Zhou
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

2.  The role of alpha-, 3(10)-, and pi-helix in helix-->coil transitions.

Authors:  Roger Armen; Darwin O V Alonso; Valerie Daggett
Journal:  Protein Sci       Date:  2003-06       Impact factor: 6.725

3.  Discrete molecular dynamics simulations of peptide aggregation.

Authors:  S Peng; F Ding; B Urbanc; S V Buldyrev; L Cruz; H E Stanley; N V Dokholyan
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2004-04-29

4.  In silico assembly of Alzheimer's Abeta16-22 peptide into beta-sheets.

Authors:  Sébastien Santini; Normand Mousseau; Philippe Derreumaux
Journal:  J Am Chem Soc       Date:  2004-09-22       Impact factor: 15.419

5.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

6.  Aqueous urea solution destabilizes Abeta(16-22) oligomers.

Authors:  D K Klimov; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

7.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

8.  Membrane water-penetration profiles from spin labels.

Authors:  Derek Marsh
Journal:  Eur Biophys J       Date:  2002-12       Impact factor: 1.733

9.  Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

Authors:  Hilal A Lashuel; Dean M Hartley; Benjamin M Petre; Joseph S Wall; Martha N Simon; Thomas Walz; Peter T Lansbury
Journal:  J Mol Biol       Date:  2003-09-26       Impact factor: 5.469

10.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

View more
  13 in total

1.  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolf Wrasidlo; Cassia Overk; Tania Gonzalez; Margarita Trejo; Brian Spencer; Kori Kosberg; Eliezer Masliah
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

2.  Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.

Authors:  Brian Spencer; Rewati Potkar; Jeff Metcalf; Ivy Thrin; Anthony Adame; Edward Rockenstein; Eliezer Masliah
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

Review 3.  Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue.

Authors:  Sylvain E Lesne
Journal:  Swiss Med Wkly       Date:  2014-11-06       Impact factor: 2.193

Review 4.  The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.

Authors:  Min Xia; Xiaofang Cheng; Ruofan Yi; Dong Gao; Jiaxiang Xiong
Journal:  Mol Neurobiol       Date:  2014-12-04       Impact factor: 5.590

Review 5.  Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.

Authors:  Kirsten L Viola; William L Klein
Journal:  Acta Neuropathol       Date:  2015-01-22       Impact factor: 17.088

Review 6.  Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

7.  Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Authors:  Brian Spencer; Paula A Desplats; Cassia R Overk; Elvira Valera-Martin; Robert A Rissman; Chengbiao Wu; Michael Mante; Anthony Adame; Jazmin Florio; Edward Rockenstein; Eliezer Masliah
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

8.  Small molecule NPT-440-1 inhibits ionic flux through Aβ1-42 pores: Implications for Alzheimer's disease therapeutics.

Authors:  Alan L Gillman; Joon Lee; Srinivasan Ramachandran; Ricardo Capone; Tania Gonzalez; Wolf Wrasidlo; Eliezer Masliah; Ratnesh Lal
Journal:  Nanomedicine       Date:  2016-06-19       Impact factor: 5.307

Review 9.  Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

Authors:  Sergio T Ferreira; Mychael V Lourenco; Mauricio M Oliveira; Fernanda G De Felice
Journal:  Front Cell Neurosci       Date:  2015-05-26       Impact factor: 5.505

10.  A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor.

Authors:  Huanyao Gao; Utkarsh Tripathi; Sergey Trushin; Lela Okromelidze; Nicholas P Pichurin; Lixuan Wei; Yongxian Zhuang; Liewei Wang; Eugenia Trushina
Journal:  Mitochondrion       Date:  2021-02-19       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.